The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ph/T might be another promising option, and it is US Food and Drug Administration approved for people aged 12 years or older with obesity (128, 129). However, this drug has not yet been tested in patients with hypothalamic obesity.”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis
Bray, G. A., & York, D. A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.719 · Cited by 1,132
BERTHOUD, H. R., & JEANRENAUD, B. (1979) · Endocrinology · doi:10.1210/endo-105-1-146 · Cited by 266
Research works printed but not linked: 39
- Rosenbaum, 1997, Obesity, N Engl J Med, 337, 396, 10.1056/NEJM199708073370606 · DOI · Paper page
- Stahnke, 1984, Long-term follow-up of children with craniopharyngioma, Eur J Pediatr, 142, 179, 10.1007/BF00442445 · DOI
- Didi, 1995, High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia of childhood, J Pediatr, 127, 63, 10.1016/S0022-3476(95)70258-X · DOI · Paper page
- Sorva, 1988, Children with craniopharyngioma: early growth failure and rapid postoperative weight gain, Acta Paediatr Scand, 77, 587, 10.1111/j.1651-2227.1988.tb10705.x · DOI
- Bray, 1975, Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature, Medicine, 54, 301, 10.1097/00005792-197507000-00002 · DOI · Paper page
- Bray, 1984, Syndromes of hypothalamic obesity in man, Pediatr Ann, 13, 525
- Reeves, 1972, Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm, Arch Neurol, 20, 616, 10.1001/archneur.1969.00480120062005 · DOI · Paper page
- Jeanrenaud, 1985, An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause, Diabetologia, 28, 502, 10.1007/BF00281984 · DOI
- Powley, 1981, Neural pathways involved in the hypothalamic integration of autonomic responses, Diabetologia, 20, 378, 10.1007/BF00254506 · DOI
- Sklar, 1994, Craniopharyngioma: endocrine sequalae of treatment, Pediatr Neurosurg, 21, 120, 10.1159/000120873 · DOI
- Ionescu, 1983, Increases in plasma insulin levels in response to electrical stimulation of the dorsal motor nucleus of the vagus nerve, Endocrinology, 112, 904, 10.1210/endo-112-3-904 · DOI
- Rohner-Jeanrenaud, 1985, Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity, Endocrinology, 116, 830, 10.1210/endo-116-2-830 · DOI
- Krentz, 1994, Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations, Metabolism, 43, 24, 10.1016/0026-0495(94)90153-8 · DOI
- Lamberts, 1996, Drug therapy: octreotide, N Engl J Med, 334, 246, 10.1056/NEJM199601253340408 · DOI · Paper page
- Hsu, 1991, Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta-cell, J Biol Chem, 266, 837, 10.1016/S0021-9258(17)35249-3 · DOI
- Weldon, 1975, Evaluation of growth hormone release in children using arginine and l -dopa in combination, J Pediatr, 87, 540, 10.1016/S0022-3476(75)80816-X · DOI
- Rosenbloom, 1975, Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents, Diabetes, 24, 820, 10.2337/diabetes.24.9.820 · doi:10.2337/diabetes.24.9.820
- Weir, 1997, Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis, Acta Diabetol, 34, 177, 10.1007/s005920050071 · DOI
- Tokunaga, 1986, Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions, Endocrinology, 119, 1708, 10.1210/endo-119-4-1708 · DOI
- Inoue, 1977, The effect of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic lesions, Endocrinology, 100, 108, 10.1210/endo-100-1-108 · DOI · Paper page
- Smith, 1983, Truncal vagotomy in hypothalmic obesity, Lancet, 1, 1330, 10.1016/S0140-6736(83)92437-6 · DOI
- Bertoli, 1998, Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity, Horm Res, 49, 17, 10.1159/000023120 · doi:10.1159/000023120
- Orskov, 1996, Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus, Metabolism, 45, 211, 10.1016/S0026-0495(96)90056-6 · DOI
- Guy-Grand, 1995, Clinical studies with dexfenfluramine: from past to future, Obes Res, 3, 491S, 10.1002/j.1550-8528.1995.tb00217.x · DOI
- Ryan, 1995, Sibutramine: a novel new agent for obesity treatment, Obes Res, 3, S553, 10.1002/j.1550-8528.1995.tb00227.x · DOI
- Lunetta, 1996, Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans, J Endocrinol Invest, 19, 699, 10.1007/BF03349042 · DOI
- Simsolo, 1995, Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase, J Clin Endocrinol Metab, 80, 3233, 10.1210/jc.80.11.3233 · doi:10.1210/jc.80.11.3233
- Simón, 1988, Characterization of somatostatin binding sites in isolated rat adipocytes, Regul Pept, 23, 261, 10.1016/0167-0115(88)90226-1 · doi:10.1016/0167-0115(88)90226-1
- Campbell, 1988, Inhibition of growth hormone-stimulated lipolysis by somatostatin, insulin, and insulin-like growth factors (somatomedins) in vitro, Proc Soc Exp Biol Med, 189, 362, 10.3181/00379727-189-42819 · doi:10.3181/00379727-189-42819
- Misra, 1994, Localization of sequences for the basal and insulin-like growth factor-1 inducible activity on the fatty acid synthase promoter in 3T3-L1 fibroblasts, Biochem J, 298, 575, 10.1042/bj2980575 · DOI
- Lotter, 1981, Somatostatin decreases food intake of rats and baboons, J Comp Physiol Psychol, 95, 278, 10.1037/h0077777 · doi:10.1037/h0077777
- Levine, 1982, Peripherally administered somatostatin reduces feeding by a vagal mediated mechanism, Pharmacol Biochem Behav, 16, 897, 10.1016/0091-3057(82)90041-7 · doi:10.1016/0091-3057(82)90041-7
- Lamberts, 1994, Somatostatin and the concept of peptide receptor scintigraphy in oncology, Semin Oncol, 21, 1
- Kaplowitz, 1998, Weight relative to height before and during growth hormone therapy in prepubertal children, Horm Metab Res, 30, 565, 10.1055/s-2007-978934 · doi:10.1055/s-2007-978934
- Ramsay, 1996, Fat cells, Endocrinol Metab Clin North Am, 25, 847, 10.1016/S0889-8529(05)70358-3 · DOI
- Campfield, 1995, Insulin normalization as an approach to the pharmacological treatment of obesity, Obes Res, 3, 591S, 10.1002/j.1550-8528.1995.tb00231.x · DOI
- Alemzadeh, 1998, Beneficial effect of diazoxide in obese hyperinsulinemic adults, J Clin Endocrinol Metab, 83, 1911, 10.1210/jc.83.6.1911 · DOI
- Molloy PT, Berkowitz R, Stallings VA, Krell H, Sutton LN, Vaughan SN, et al. Pilot study of evaluation and treatment of tumor-related obesity in pediatric patients with hypothalamic/chiasmatic gliomas and craniopharyngiomas [abstract]. Eighth International Symposium on Neuro-oncology; 1998 May 6-9; Rome, Italy.
- Mason, 1998, Use of dextroamphetamine for weight control in children following surgery for suprasellar tumors [abstract], Endocr Soc, 80, P1
Cited by
Childhood obesity: public-health crisis, common sense cure
Ebbeling, C. B., Pawlak, D. B., & Ludwig, D. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09678-2 · Cited by 2,980
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Yanovski, S. Z., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012586 · Cited by 544
August, G. P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F. R., Lustig, R. H., Silverstein, J. H., Speiser, P. W., Styne, D. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2458 · Cited by 524
Self-citationCurrent and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
Metadata
- Authors
- Lustig, R. H., Rose, S. R., Burghen, G. A., Velasquez-Mieyer, P., Broome, D. C., Smith, K., Li, H., Hudson, M. M., Heideman, R. L., & Kun, L. E.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 135
- Issue
- 2
- Pages
- 162-168
- ISSN
- 0022-3476
- Cited by
- 138
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. https://app.cochat.ai/papers/10.1016/s0022-3476(99)70017-x
- The paper
- Lustig, R. H., Rose, S. R., Burghen, G. A., Velasquez-Mieyer, P., Broome, D. C., Smith, K., Li, H., Hudson, M. M., Heideman, R. L., & Kun, L. E. (1999). Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(99)70017-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.